Consensus statementA pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A
References (51)
- et al.
Drug substitution in transplantation: A National Kidney Foundation White Paper
Am J Kidney Dis
(1999) Cyclosporine: The case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets
Therapeutic monitoring for cyclosporine: Difficulties in establishing a therapeutic window
Clin Biochem
(1991)- et al.
Generic substitution for cyclosporine: What should we be looking for in new formulations?
- et al.
Bioequivalence criteria for cyclosporine
- et al.
Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients
Am J Kidney Dis
(1999) British National Formulary 41
(March 2001)Substitution of Critical Dose Drugs: Issues, Analysis and Decision Making
(2000)- et al.
Cyclosporine pharmacokinetics and variability from a microemulsion formulation—a multicenter investigation in kidney transplant patients
Transplantation
(1994) - et al.
Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplanation
Clin Pharmacol Ther
(1993)
Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection
Transplantation
(1996)
Challenges in cyclosporine therapy: The role of therapeutic monitoring by area under the curve monitoring
Ther Drug Monit
(1995)
Critical therapeutic categories: A contraindication to generic substitution?
Clin Ther
(1986)
Approved Drug Products with Therapeutic Equivalence Evaluations
Simple bioequivalence criteria: Are they relevant to critical dose drugs? Experience gained from cyclosporine
Ther Drug Monit
(1997)
Cyclosporine kinetics in healthy volunteers
J Clin Pharmacol
(1987)
Cyclosporin pharmacokinetics in paediatric transplant recipients
Clin Pharmacokinet
(1997)
Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients
Transplantation
(1997)
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations
The adverse impact of high cyclosporine clearance rates on the incidences of acute rejection and graft loss
Transplantation
(1993)
Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis
Transplantation
(1990)
Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis
Ther Drug Monit
(1990)
Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals
Transplantation
(1995)
Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients
Transplantation
(1999)
Cited by (0)
Copyright © 2003 Published by Elsevier Inc.